AllSight
Companies
· GENB · Pharmaceutical Preparations
Generate Biomedicines, Inc. (GENB)
Every material event, decoded in plain English — what each one means for the stock.
Aug 25, 2026
Phase 1 update
Generate Biomedicines backs six-month GB-0895 dosing, but Phase 3 must prove outcomes
Related companies in Pharmaceutical Preparations
ONC
ELAN
CMPS
UTHR
PRGO
ETON
QTTB
LLY
NAMS
RAPP
SMMT
RPRX
Open live on AllSight — the whole market, decoded →